Please protect the confidentiality of your patients by not revealing or sharing login credentials.
FOR U.S. HEALTHCARE PROFESSIONALS ONLY
<style>@font-face {
  font-family: 'Open Sans';
  src: local('Open Sans'), url(https://themes.googleusercontent.com/static/fonts/opensans/v8/cJZKeOuBrn4kERxqtaUH3bO3LdcAZYWl9Si6vvxL-qU.woff) format('woff');
}

#opensan

{

  font-family: 'Open Sans';

}

</style> <div id="opensan">
Register Now
</div>

If you are a new user to the site, please click the Register Now button to begin the registration process.

If you are a registered user, please login above.



Product Information


Contact Us

Patient Phone/Fax Numbers

Janssen CarePath for PROCRIT®:
  1-800-553-3851
  1-800-987-5572 (Fax)

Janssen CarePath for YONDELIS®:
  1-844-YONDELIS (844-966-3354)
  1-844-966-3353 (Fax)

Janssen CarePath for DARZALEX®:
  1-844-55DARZA (844-553-2792)
  1-844-553-2793 (Fax)

8:00 AM to 8:00 PM ET,
Contact Address
Janssen CarePath for PROCRIT®
and YONDELIS®
P.O. Box 220247
Charlotte, NC 28222-0247
Janssen CarePath for DARZALEX®
P.O. Box 220307
Charlotte NC 28222-0307

janssencarepath

Before prescribing PROCRIT® please see full Prescribing Information, including Boxed Warnings, and Medication Guide available at www.PROCRIT.com.

Before prescribing YONDELIS® please see full Prescribing Information, including DOSAGE and ADMINISTRATION, WARNINGS and PRECAUTIONS, available at www.YONDELIS.com.

Before prescribing DARZALEX® please see full Prescribing Information including DOSAGE and ADMINISTRATION, WARNINGS and PRECAUTIONS, available at www.DARZALEX.com.

Patient insurance benefit investigation is provided as a service by the support services administrator under contract for Janssen Biotech, Inc. In this regard, the support services administrator assists healthcare professionals in the determination of whether treatment could be covered by the applicable third-party payer based on coverage guidelines provided by the payer and patient information provided by the healthcare provider under appropriate authorization following the providers' exclusive determination of medical necessity.

Importantly, insurance verification is the ultimate responsibility of the provider. Third-party reimbursement is affected by many factors. Therefore, the support services administrator, and Janssen Biotech, Inc., make no representation or guarantee that full or partial insurance reimbursement or any other payment will be available. This information is provided as an information service only. While the support services administrator tries to provide correct information, it and Janssen Biotech, Inc., make no representations or warranties, expressed or implied, as to the accuracy of the information. In no event shall the support services administrator, or Janssen Biotech, Inc., or its employees, or agents be liable for any damages resulting from or relating to the services. All providers and other users of this information agree that they accept responsibility for the use of this service.

Janssen Biotech, Inc., assumes no responsibility for, and does not guarantee, the quality, scope, or availability of the services including, but not limited to, reimbursement support services, patient education, and other support services. Each provider, not Janssen Biotech, Inc., is responsible for the services they provide. These support services have no independent value to providers apart from the product and are included within the cost of the product.

WARNING NOTICE: You are about to enter a private Web site that is restricted to authorized use by Janssen Biotech, Inc., and their authorized agents ("the Company") for business purposes only. The actual or attempted unauthorized access, use, or modification of the Web site and its contents is strictly prohibited by the Company. Unauthorized users and/or unauthorized use are subject to criminal and/ or civil penalties in accordance with applicable domestic and foreign laws. The use of this Web site may be monitored and recorded for administrative and security reasons. If such monitoring and/or recording reveals possible evidence of criminal activity, the Company may provide the monitored evidence of such activity to law enforcement officials. Access to this application from an untrusted workstation, including, but not limited to, cyber cafes and public kiosks, is prohibited.